Peter Albers. Show Affiliations »
Abstract
Mesh: See more » EuropeHumansMaleMass ScreeningProstatic Neoplasms/diagnosisProstatic Neoplasms/mortalityRandomized Controlled Trials as TopicSurvival Rate
Year: 2006 PMID: 16949198 DOI: 10.1016/j.eururo.2006.07.044
Source DB: PubMed Journal: Eur Urol ISSN: 0302-2838 Impact factor: 20.096